7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Atrial Remodeling D064752 1 associated lipids
Vascular Calcification D061205 1 associated lipids
Angina, Stable D060050 2 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Osteoporotic Fractures D058866 1 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Peri-Implantitis D057873 1 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Osteophyte D054850 2 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Hypercalciuria D053565 4 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Fractures, Bone D050723 4 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Atherosclerosis D050197 85 associated lipids
Dyslipidemias D050171 7 associated lipids
Hashimoto Disease D050031 1 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Diabetes Complications D048909 4 associated lipids
Hypertension, Pregnancy-Induced D046110 2 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Malnutrition D044342 6 associated lipids
Irritable Bowel Syndrome D043183 8 associated lipids
Mastocytoma D034801 3 associated lipids
Hearing Loss D034381 3 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Spondylarthropathies D025242 1 associated lipids
Spondylarthritis D025241 1 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Coronary Stenosis D023921 6 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Brain Infarction D020520 17 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Lithiasis D020347 2 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Venous Thrombosis D020246 11 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Hot Flashes D019584 5 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Myositis, Inclusion Body D018979 3 associated lipids
Sepsis D018805 11 associated lipids
Arthralgia D018771 8 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Foot Injuries D018409 1 associated lipids
Alphavirus Infections D018354 1 associated lipids
Hemangioma, Capillary D018324 1 associated lipids
Neoplasms, Squamous Cell D018307 1 associated lipids
Carcinoma, Neuroendocrine D018278 2 associated lipids
Carcinoma, Medullary D018276 2 associated lipids
Carcinoma, Lobular D018275 4 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Adrenocortical Adenoma D018246 1 associated lipids
Fibroma, Ossifying D018214 1 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Lymphangioleiomyomatosis D018192 1 associated lipids
Bone Cysts, Aneurysmal D017824 2 associated lipids
Diabetic Foot D017719 1 associated lipids
Periodontal Attachment Loss D017622 7 associated lipids
Microvascular Angina D017566 2 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Myocardial Ischemia D017202 11 associated lipids
beta-Thalassemia D017086 5 associated lipids
Arthritis, Reactive D016918 3 associated lipids
Carotid Stenosis D016893 15 associated lipids
POEMS Syndrome D016878 1 associated lipids
Pasteurellaceae Infections D016871 2 associated lipids
Bacteroidaceae Infections D016866 2 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Bacteremia D016470 9 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Fractures, Stress D015775 2 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
HIV Infections D015658 20 associated lipids
Histiocytosis, Non-Langerhans-Cell D015616 4 associated lipids
Hyperostosis D015576 1 associated lipids
Arthritis, Psoriatic D015535 3 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Weight Loss D015431 56 associated lipids
Weight Gain D015430 101 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
pmid:24862732
Chen H et al. Runx2 regulates endochondral ossification through control of chondrocyte proliferation and differentiation. 2014 J. Bone Miner. Res. pmid:24862038
Wang Y et al. Puerarin concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production in human osteoblastic MG-63 cells. Phytomedicine pmid:24854571
pmid:24853718
Shimamura M et al. OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:24847069
pmid:24845712
pmid:24833640
pmid:24830656
Li B et al. Periodontal ligament stem cells modulate root resorption of human primary teeth via Runx2 regulating RANKL/OPG system. 2014 Stem Cells Dev. pmid:24827498
Lee SI et al. NOD2 Mediates Odontoblast Differentiation and RANKL Expression. 2014 J. Dent. Res. pmid:24820666
Araújo AA et al. Azilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model. 2014 PLoS ONE pmid:24819928
Cianciolo G et al. Importance of vascular calcification in kidney transplant recipients. 2014 Am. J. Nephrol. pmid:24819032
Kuroyanagi G et al. Suppression by resveratrol of prostaglandin D2-stimulated osteoprotegerin synthesis in osteoblasts. 2014 Prostaglandins Leukot. Essent. Fatty Acids pmid:24813642
Shao X et al. Metformin rescues the MG63 osteoblasts against the effect of high glucose on proliferation. 2014 J Diabetes Res pmid:24812633
pmid:24811358
Jin Y et al. Functional role of mechanosensitive ion channel Piezo1 in human periodontal ligament cells. 2015 Angle Orthod pmid:24810489
pmid:24810471
Sänger N et al. OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer. 2014 Mol Oncol pmid:24785095
Park MK et al. Halofuginone ameliorates autoimmune arthritis in mice by regulating the balance between Th17 and Treg cells and inhibiting osteoclastogenesis. 2014 pmid:24782183
Hooshmand S et al. The effect of dried plum on serum levels of receptor activator of NF-κB ligand, osteoprotegerin and sclerostin in osteopenic postmenopausal women: a randomised controlled trial. 2014 Br. J. Nutr. pmid:24780728
pmid:24769277
pmid:24767864
pmid:24767560
Hidayat R et al. Correlation between receptor activator of nuclear factor-κβ ligand (RANKL), and osteoprotegerin (OPG) with cartilage degradation in rheumatoid arthritis patients. 2014 Acta Med Indones pmid:24760805
pmid:24758546
Milanova V et al. TLR2 elicits IL-17-mediated RANKL expression, IL-17, and OPG production in neutrophils from arthritic mice. 2014 Mediators Inflamm. pmid:24757287
pmid:24757095
pmid:24756971
Akiyama T et al. Porphyromonas gingivalis-derived lysine gingipain enhances osteoclast differentiation induced by tumor necrosis factor-α and interleukin-1β but suppresses that by interleukin-17A: importance of proteolytic degradation of osteoprotegerin by lysine gingipain. 2014 J. Biol. Chem. pmid:24755218
Takeshita S et al. Age-related marrow adipogenesis is linked to increased expression of RANKL. 2014 J. Biol. Chem. pmid:24753250
Khan IS et al. Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance. 2014 J. Exp. Med. pmid:24752296
Nolen BM et al. Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. 2014 PLoS ONE pmid:24747429
pmid:24743232
Zhao JJ et al. Association analysis between the OPG g.27667T>A genetic variant and bone mineral density in Chinese postmenopausal women. 2014 Genet. Mol. Res. pmid:24737508
Chen W et al. Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:24733914
pmid:24723620
pmid:24721700
pmid:24721487
Yoo YM et al. Effects of neuropeptides and mechanical loading on bone cell resorption in vitro. 2014 Int J Mol Sci pmid:24717410
Deng L et al. Tissue distribution of emulsified γ-tocotrienol and its long-term biological effects after subcutaneous administration. 2014 Lipids Health Dis pmid:24712339
Tao K et al. Influences of IL-6R antibody on PMMA bone cement-mediated expression of OPG and RANKL in synovial fibroblasts. 2014 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:24710939
Pullisaar H et al. Simvastatin coating of TiOâ‚‚ scaffold induces osteogenic differentiation of human adipose tissue-derived mesenchymal stem cells. 2014 Biochem. Biophys. Res. Commun. pmid:24704451
Chung PL et al. Effect of age on regulation of human osteoclast differentiation. 2014 J. Cell. Biochem. pmid:24700654
pmid:24697526
pmid:24689950
pmid:24678593
Potocka-Bakłażec M et al. Expression of TNF-α, OPG, IL-1β and the presence of the measles virus RNA in the stapes of the patients with otosclerosis. 2015 Eur Arch Otorhinolaryngol pmid:24676726
Lee EJ et al. PTX3 stimulates osteoclastogenesis by increasing osteoblast RANKL production. 2014 J. Cell. Physiol. pmid:24664887
Canalis E et al. Nemo-like kinase regulates postnatal skeletal homeostasis. 2014 J. Cell. Physiol. pmid:24664870
Sirjani M et al. The effects of high fat, low carbohydrate and low fat, high carbohydrate diets on tumor necrosis factor superfamily proteins and proinflammatory cytokines in C57BL/6 mice. 2014 Iran J Allergy Asthma Immunol pmid:24659160
Lenglet S et al. Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis. 2014 Mediators Inflamm. pmid:24648660
Callegari A et al. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6. 2014 J. Vasc. Res. pmid:24642764
Wang JH et al. Association of serum osteoprotegerin levels with carotid-femoral pulse wave velocity in hypertensive patients. 2014 J Clin Hypertens (Greenwich) pmid:24640954
Ohlsson C et al. Probiotics protect mice from ovariectomy-induced cortical bone loss. 2014 PLoS ONE pmid:24637895
pmid:24629477
pmid:24627163
pmid:24621381
pmid:24615483
Liu YP et al. Association of the g.27563G>A osteoprotegerin genetic polymorphism with bone mineral density in Chinese women. 2014 Genet. Mol. Res. pmid:24615112
Hayashida C et al. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis. 2014 J. Biol. Chem. pmid:24610813
Wang Q et al. [Effects of treadmill exercise on mRNA expression levels of osteoprotegerin, RANKL and RUNX2 in bone tissues of ovariectomized]. 2013 Zhongguo Gu Shang pmid:24605748
Ovchinnikova OA et al. The collagen cross-linking enzyme lysyl oxidase is associated with the healing of human atherosclerotic lesions. 2014 J. Intern. Med. pmid:24588843
Montes de Oca A et al. Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. 2014 PLoS ONE pmid:24586847
Izawa A et al. Inflammatory bone loss in experimental periodontitis induced by Aggregatibacter actinomycetemcomitans in interleukin-1 receptor antagonist knockout mice. 2014 Infect. Immun. pmid:24566623
pmid:24566391
pmid:24559372
pmid:24555750
Ostrowska Z et al. Bone metabolism, osteoprotegerin, receptor activator of nuclear factor-κB ligand and selected adipose tissue hormones in girls with anorexia nervosa. 2014 Endokrynol Pol pmid:24549600
pmid:24533937
Park YJ et al. Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1. 2014 Lupus pmid:24531425
Casarin RC et al. Resveratrol improves bone repair by modulation of bone morphogenetic proteins and osteopontin gene expression in rats. 2014 Int J Oral Maxillofac Surg pmid:24530035
Loureiro MB et al. Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes. 2014 Diabetes Res. Clin. Pract. pmid:24529565
Rachner TD et al. Dickkopf-1 is regulated by the mevalonate pathway in breast cancer. 2014 Breast Cancer Res. pmid:24528599
Steffens JP et al. Testosterone regulates bone response to inflammation. 2014 Horm. Metab. Res. pmid:24526374
pmid:24525272
pmid:24521946
Chiang PH et al. Zoledronic acid treatment for cancerous bone metastases: a phase IV study in Taiwan. 2013 Oct-Dec J Cancer Res Ther pmid:24518712
Huang C et al. The inhibitory effect of strontium-doped calcium polyphosphate particles on cytokines from macrophages and osteoblasts leading to aseptic loosening in vitro. 2014 Biomed Mater pmid:24518283
Liu CG et al. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro]. 2013 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:24517065
Ma Y et al. Acetylcholine affects osteocytic MLO-Y4 cells via acetylcholine receptors. 2014 Mol. Cell. Endocrinol. pmid:24508663
Miller RE et al. RANKL inhibition blocks osteolytic lesions and reduces skeletal tumor burden in models of non-small-cell lung cancer bone metastases. 2014 J Thorac Oncol pmid:24496001
Kim JY et al. (2S)-2'-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling. 2014 Biol. Pharm. Bull. pmid:24492722
Zanotti S et al. Sex and genetic factors determine osteoblastic differentiation potential of murine bone marrow stromal cells. 2014 PLoS ONE pmid:24489784
Dessein PH et al. Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis. 2014 J. Rheumatol. pmid:24488413
pmid:24486161
Honma M et al. Regulatory mechanisms of RANKL presentation to osteoclast precursors. 2014 Curr Osteoporos Rep pmid:24477414
pmid:24476549
pmid:24473535
Aksu F et al. The relation between the levels of osteoprotegerin and the degree of coronary artery disease in patients with acute coronary syndrome and stable angina pectoris. 2014 Kardiol Pol pmid:24469748
Park SY et al. Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment. 2014 Toxicol. Appl. Pharmacol. pmid:24463094
Scialla JJ et al. Biomarkers of vascular calcification and mortality in patients with ESRD. 2014 Clin J Am Soc Nephrol pmid:24458076
Liu S et al. Association between g.19163A>G and g.23298T>C genetic variants of the osteoprotegerin gene and bone mineral density in Chinese women. 2013 Oct-Dec Hormones (Athens) pmid:24457406
Lewis JR et al. Elevated osteoprotegerin predicts declining renal function in elderly women: a 10-year prospective cohort study. 2014 Am. J. Nephrol. pmid:24457210
pmid:24456422
Bastos MF et al. Impact of caffeine and/or estrogen deficiency on trabecular bone area and healing: a study in rats. 2014 Jan-Feb Int J Oral Maxillofac Implants pmid:24451874
Wu H et al. Ginsenoside metabolite compound K attenuates inflammatory responses of adjuvant-induced arthritis rats. 2014 Immunopharmacol Immunotoxicol pmid:24450920
Inanc M et al. Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid. 2014 Med. Oncol. pmid:24448976
pmid:24447513
pmid:24446163
Ohba T et al. Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL. 2014 J. Bone Miner. Res. pmid:24443409

Table of Content